Gizelle Baker, VP Global Scientific Engagement, PMI and Patrick Picavet, Chief Medical Officer, PMI share the results of a study to evaluate the reduction of the Abdominal Aortic Aneurysm (AAA) annual growth rate in patients who switch from smoking cigarettes to using IQOS as compared to patients who continue to smoke cigarettes.